Positive KL-6 mucin expression combined with decreased membranous β-catenin expression indicates worse prognosis in colorectal carcinoma

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1013-1019

  Zhang, Wei ^a,b   Tang, Wei ^b,c   Inagaki, Yoshinori ^b   Qiu, Ming ^a   Xu, Huan Li ^b,c   Li, Xun ^c   Sugawara, Yasuhiko ^b   Nagawa, Hirokazu ^b   Nakata, Munehiro ^d   Kokudo, Norihiro ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHANDONG UNIVERSITY   (China)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

catenin; Colorectal carcinoma; KL 6; MUC1

Indexed keywords

BETA CATENIN; MUCIN 1; MUC1 PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; ADENOCARCINOMA; BIOSYNTHESIS; CELL MEMBRANE; COLORECTAL TUMOR; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY;

ADENOCARCINOMA; BETA CATENIN; CELL MEMBRANE; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MUCIN-1; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149350380     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000103     Document Type: Article

References (33)

1. Behrens J: The role of the Wnt signaling pathway in colorectal tumorigenesis. Biochem Soc Trans 33: 672-675, 2005.
2. Ozawa M, Baribault H and Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1989.
3. Fuchs SY, Ougolkov AV, Spiegelman VS and Minamoto T: Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle 4: 1522-1539, 2005.
4. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916-932, 1999.
5. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
6. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
7. Huang L, Chen D, Liu D, Yin L, Kharbanda S and Kufe D: MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 65: 10413-10422, 2005.
8. Wen Y, Caffrey TC, Wheelock MJ, Johnson KR and Hollingsworth MA: Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem 278: 38029-38039, 2003.
9. Li Y, Bharti A, Chen D, Gong J and Kufe D: Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol 18: 7216-7224, 1998.
10. Huang L, Ren J, Chen D, Li Y, Kharbanda S and Kufe D: MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther 2: 702-706, 2003.
11. Schroeder JA, Adriance MC, Thompson MC, Camenisch TD and Gendler SJ: MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 22: 1324-1332, 2003.
12. Hollingsworth MA and Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60, 2004.
13. Byrd JC and Bresalier RS: Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23: 77-99, 2004.
14. Rahn JJ, Dabbagh L, Pasdar M and Hugh JC: The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 91: 1973-1982, 2001.
15. Cao Y, Schlag PM and Karsten U: Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation. Virchows Arch 431: 59-66, 1997.
16. Japanese Society for Cancer of the Colon and Rectum. In: Japanese classification of colorectal carcinoma (ed). 1st English edition. Kanehara, Tokyo, 1997.
17. Sobin LH and Wittekind CH: International Union Against Cancer (UICC). In: TNM classification of the malignant tumor (eds). 5th edition. Wiley-Liss Publications, New York, 1997.
18. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 59: 302-309, 2000.
19. Tang W, Miki K, Kokudo N, Sugawara Y, Imamura H, Minagawa M, Yuan LW, Ohnishi S and Makuuchi M: Desgamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma. Int J Oncol 22: 969-975, 2003.
20. Guo Q, Tang W, Inagaki Y, Midorikawa Y, Kokudo N, Sugawara Y, Nakata M, Konishi T, Nagawa H and Makuuchi M: Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol 12: 54-59, 2006.
21. Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Holscher AH and Dienes HP: MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10: 2790-2796, 2004.
22. Guo Q, Tang W, Inagaki Y, Kokudo N, Sugawara Y, Karako H, Nakata M and Makuuchi M: Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: Association with metastatic potential and cell morphology. Oncol Rep 17: 1057-1060, 2007.
23. Tang W, Kokudo N, Sugawara Y, Guo Q, Imamura H, Sano K, Karako H, Qu X, Nakata M and Makuuchi M: Des-gamma-carboxyprothrombin expression in cancer and/or non-cancer liver tissues: association with survival of patients with resectable hepatocellular carcinoma. Oncol Rep 13: 25-30, 2005.
24. Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, Han J and Kim J: Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 24: 441-449, 2003.
25. Ohno T, Aihara R, Kamiyama Y, Mochiki E, Asao T and Kuwano H: Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Eur J Cancer 42: 256-263, 2006.
26. van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA and Schalken JA: The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120(ctn) in prostate cancer specific survival: A long-term follow-up study. Prostate 67: 1432-1438, 2007.
27. Fernebro E, Bendahl PO, Dictor M, Persson A, Fernö M and Nilbert M: Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations. Int J Cancer 111: 921-928, 2004.
28. Han SA, Chun H, Park CM, Kang SJ, Kim SH, Sohn D, Yun SH and Lee WY: Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Clin Oncol (R Coll Radiol) 18: 761-767, 2006.
29. Wong SC, Lo ES, Lee KC, Chan JK and Hsiao WL: Prognostic and diagnostic significance of beta-catenin nuclear immuno-staining in colorectal cancer. Clin Cancer Res 10: 1401-1408, 2004.
30. Horkko TT, Klintrup K, Makinen JM, Napankangas JB, Tuominen HJ, Makela J, Karttunen TJ and Makinen MJ: Budding invasive margin and prognosis in colorectal cancer - no direct association with beta-catenin expression. Eur J Cancer 42: 964-971, 2006.
31. Gunther K, Brabletz T, Kraus C, Dworak O, Reymond MA, Jung A, Hohenberger W, Kirchner T, Kockerling F and Ballhausen WG: Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum 41: 1256-1261, 1998.
32. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K and Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18: 203-216, 1988.
33. Wesseling J, van der Valk SW and Hilkens J: A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7: 565-577, 1996.